Basis for the ICRP’s updated biokinetic model for carbon inhaled as CO2

This paper describes an updated biokinetic model for systemic sodium (Na), developed for use in a series of reports by the International Commission on Radiological Protection (ICRP) on occupational intake of radionuclides. In contrast to the ICRP’s previous model for intake of radio-sodium by workers, the updated model depicts realistic directions of movement of Na in the body including recycling of activity between blood and tissues. The updated model structure facilitates extension of the baseline transfer coefficients for adults to different age groups and to special exposure scenarios such as transfer of radio-sodium from the mother to the foetus or the nursing infant. Dose coefficients for 22Na and 24Na based on the updated model generally do not differ greatly from those based on the ICRP’s previous Na model when both models are connected to the ICRP’s latest dosimetry system. The main exception is that the updated model yields roughly twofold higher dose coefficients for endosteal bone surface than does the previous model due to the dosimetrically cautious assumption in the updated model that exchangeable Na in bone resides on bone surface.

The International Commission on Radiological Protection (ICRP) recently updated its biokinetic models for workers in a series of reports called the OIR (occupational intakes of radionuclides) series. A new biokinetic model for astatine (At), the heaviest member of the halogen family, was adopted in OIR Part 5 (ICRP in press). Occupational intakes of radionuclides: Part 5). This paper provides an overview of available biokinetic data for At; describes the basis for the ICRP’s updated model for At; and tabulates dose coefficients for intravenous injection of each of the two longest lived and most important At isotopes, 211At and 210At. At-211 (T 1/2 = 7.214 h) is a promising radionuclide for use in targeted α-particle therapy due to several favourable properties including its half-life and the absence of progeny that could deliver significant radiation doses outside the region of α-particle therapy. At-210 (T 1/2 = 8.1 h) is an impurity generated in the production of 211At in a cyclotron and represents a potential radiation hazard via its long-lived progeny 210Po (T 1/2 = 138 days). Tissue dose coefficients for injected 210At and 211At based on the updated model are shown to differ considerably from values based on the ICRP’s previous model for At, particularly for the thyroid, stomach wall, salivary glands, lungs, spleen, and kidneys.

ICRP Task Group 95: internal dose coefficients.

In this issue (page 101), Hunt reports studies in which volunteers consumed cockles from the Irish Sea and measurements were made of the absorption of radionuclides, including the alpha-emitting actinide nuclides, 239Pu and 241Am. Previously, Hunt and colleagues (1986, 1990, 1993) have reported similar studies of the absorption of 239Pu and 241Am from Cumbrian winkles and mussels and of the naturally occurring alpha-emitter, 210Pu, from crabmeat. Their principal motivation has been to improve estimates of radiation doses to specific critical groups of seafood consumers in the coastal communities; in so doing they have provided valuable information for more general assessments of dose and risk. Studies of the absorption of 239Pu and 241Am have involved the measurement of declining levels as a result of continued reductions in marine discharges from Sellafield and somewhat delayed reductions in concentrations in shellfish. The greatest critical group doses from 239Pu and 241Am are now substantially lower than doses from natural 210Po.

The biokinetic model for systemic americium (Am) currently recommended by the International Commission on Radiological Protection (ICRP) for application to occupational intake of Am is based on information available through the early 1990s. Much additional information on Am biokinetics has been developed in the past 25 y, including measurements of retention and excretion of 241Am in many workers with 241Am burdens and post mortem measurements of 241Am in tissues of some of those workers. The ICRP’s current Am model is reasonably consistent with the updated information, with the main exception that the current model apparently overestimates 24-hour urinary Am as a fraction of skeletal or systemic Am at late times after intake. This paper provides an overview of current information on the systemic kinetics of Am in adult human subjects and laboratory animals and presents an updated biokinetic model for systemic Am that addresses the discrepancies between the current database and current ICRP systemic model for Am. This model is applied in Part 4 (to appear) of an ICRP series of reports on intake of radionuclides by workers called the OIR (Occupational Intake of Radionuclides) series.

Radiation dosimetry is central to virtually all radiation safety applications, optimization, and research. It relates to various individuals and population groups and to miscellaneous exposure situations—including planned, existing, and emergency situations. The International Commission on Radiological Protection (ICRP) has developed a new computational framework for internal dose estimations. Important components are more detailed and improved anatomical models and more realistic biokinetic models than before. The ICRP is currently producing new organ dose and effective dose coefficients for occupational intakes of radionuclides (OIR) and environmental intakes of radionuclides (EIR), which supersede the earlier dose coefficients in Publication 68 and the Publication 72 series, respectively. However, the ICRP only publishes dose coefficients for a single acute intake of a radionuclide and for an integration period of 50 years for intake by adults and to age 70 years for intakes by pre-adults. The new software, IDAC-Bio, performs committed absorbed dose and effective dose calculations for a selectable intake scenario, e.g., for a continuous intake or an intake during x hours per day and y days per week, and for any selected integration time. The software uses the primary data and models of the ICRP biokinetic models and numerically solves the biokinetic model and calculates the absorbed doses to organs and tissues in the ICRP reference human phantoms. The software calculates absorbed dose using the nuclear decay data in ICRP publication 107. IDAC-Bio is a further development and an important addition to the internal dosimetry program IDAC-Dose2.1. The results generated by the software were validated against published ICRP dose coefficients. The potential of the software is illustrated by dose calculations for a nuclear power plant worker who had been exposed to varying levels of 60Co and who had undergone repeated whole-body measurements, and for a hypothetical member of the public subject to future releases of 148Gd from neutron spallation in tungsten at the European Spallation Source.

Improving the reliability of internal dosimetry for uranium workers: Application of the ICRP/OIR uranium model to long-term occupational intakes

Workshop on Intakes of Radionuclides: Occupational and Public Exposure, Avignon, 15-18 September 1997

To facilitate the estimation of radiation doses from intake of radionuclides, the International Commission on Radiological Protection (ICRP) publishes dose coefficients (dose per unit intake) based on reference biokinetic and dosimetric models. The ICRP generally has not provided biokinetic models or dose coefficients for intake of noble gases, but plans to provide such information for 222Rn and other important radioisotopes of noble gases in a forthcoming series of reports on occupational intake of radionuclides (OIR). This paper proposes a generic biokinetic model framework for noble gases and develops parameter values for radon. The framework is tailored to applications in radiation protection and is consistent with a physiologically based biokinetic modelling scheme adopted for the OIR series. Parameter values for a noble gas are based largely on a blood flow model and physical laws governing transfer of a non-reactive and soluble gas between materials. Model predictions for radon are shown to be consistent with results of controlled studies of its biokinetics in human subjects.

Application of INTDOSKIT tool for assessment of uncertainties on dose coefficients for ingestion of uranium by workers

The objective of the present work is to apply the plasma clearance parameters to strontium, previously determined in our laboratory, to improve the biokinetic and dosimetric models of strontium-90 ((90)Sr) used in radiological protection; and also to apply this data for the estimation of the radiation doses from strontium-89 ((89)Sr) after administration to patients for the treatment of the painful bone metastases. Plasma clearance and urinary excretion of stable strontium tracers of strontium-84 ((84)Sr) and strontium-86 ((86)Sr) were measured in GSF-National Research Center for Environment and Health (GSF) in 13 healthy German adult subjects after intravenous injection and oral administration. The biological half-life of strontium in plasma was evaluated from 49 plasma concentration data sets following intravenous injections. This value was used to determine the transfer rates from plasma to other organs and tissues. At the same time, the long-term retention of strontium in soft tissue and whole body was constrained to be consistent with measured values available. A physiological urinary path was integrated into the biokinetic model of strontium. Parameters were estimated using our own measured urinary excretion values. Retention and excretion of strontium were modeled using compartmental transfer rates published by the International Commission on Radiological Protection (ICRP), the SENES Oak Ridge Inc. (SENES), and the Urals Research Center for Radiation Medicine (TBM). The results were compared with values calculated by applying our GSF parameters (GSF). For the dose estimation of (89)Sr, a bone metastases model (GSF-M) was developed by adding a compartment, representing the metastases, into the strontium biokinetic model. The related parameters were evaluated based on measured data available in the literature. A set of biokinetic parameters was optimized to represent not only the early plasma kinetics of strontium but also the long-term retention measured in soft tissue and whole body. The ingestion dose coefficients of (90)Sr were computed and compared with different biokinetic model parameters. The ingestion dose coefficients were calculated as 2.8 x 10(-8), 2.1 x 10(-8), 2.5 x 10(-8) and 3.8 x 10(-8) Sv Bq(-1) for ICRP, SENES, TBM and GSF model parameters, respectively. Moreover, organ absorbed dose for the radiopharmaceutical of (89)Sr in bone metastases therapy was estimated based on the GSF and ICRP biokinetic model parameters. The effective doses were 3.3, 1.8 and 1.2 mSv MBq(-1) by GSF, GSF-M, and ICRP Publication 67 model parameters, respectively, compared to the value of 3.1 mSv MBq(-1) reported by ICRP Publication 80. The absorbed doses of red bone marrow and bone surface, 17 and 21 mGy MBq(-1) calculated by GSF parameters, and 7.1 and 8.8 mGy MBq(-1) by GSF-M parameters, are comparable to the clinical results of 3-19 mGy MBq(-1) for bone marrow and 16 mGy MBq(-1) for bone surface. Based on the GSF-M model, the absorbed dose of (89)Sr to metastases was estimated to be 434 mGy MBq(-1). The strontium clearance half-life of 0.25 h from the plasma obtained in the present study is obviously faster than the value of 1.1 h recommended by ICRP. There are no significant changes for ingestion dose coefficients of (90)Sr using different model parameters. A model including the metastases was particularly developed for dose estimation of (89)Sr treatment for the pain of bone metastases.

The International Commission on Radiological Protection (ICRP) has recently published two reports on radon exposure; Publication 115 on lung cancer risks from radon and radon progeny and Publication 126 on radiological protection against radon exposure. A specific graded approach for the control of radon in workplaces is recommended where a dose assessment is required in certain situations. In its forthcoming publication on Occupational Intakes of Radionuclides (OIR) document, Part 3, effective dose coefficients for radon and thoron will be provided. These will be calculated using ICRP reference biokinetic and dosimetric models. Sufficient information and dosimetric data will be given so that site-specific dose coefficients can be calculated based on measured aerosol parameter values. However, ICRP will recommend a single dose coefficient of 12 mSv per working level month (WLM) for inhaled radon progeny to be used in most circumstances. This chosen reference value was based on both dosimetry and epidemiological data. In this paper, the application and use of dose coefficients for workplaces are discussed including the reasons for the choice of the reference value. Preliminary results of dose calculations for indoor workplaces and mines are presented. The paper also briefly describes the general approach for the management of radon exposure in workplaces based both on ICRP recommendations and the European directive (2013/59/EURATOM).

This letter to the editor of Journal of Radiological Protection is in response to a letter to the editor from G. M. Smith and M. C. Thorne of Great Britain concerning the appropriate selection of dose coefficients for ingested carbon-14 and chlorine-36, two of the most important long-lived components of radioactive wastes. Smith and Thorne argue that current biokinetic models of the International Commission on Radiological Protection (ICRP) for carbon and chlorine are overly cautious models from the standpoint of radiation dose estimates for C-14 and Cl-36, and that more realistic models are needed for evaluation of the hazards of these radionuclides in nuclear wastes. We (Harrison and Leggett) point out that new biokinetic models for these and other elements (developed at ORNL) will soon appear in ICRP Publications. These new models generally are considerably more realistic than current ICRP models. Here, examples are given for C-14 inhaled as carbon dioxide or ingested in water as bicarbonate, carbonate, or carbon dioxide.

The International Commission on Radiological Protection (ICRP) is preparing a series of reports that will provide updated biokinetic and dosimetric models and dose coefficients for occupational intake of radionuclides. The biokinetic modelling scheme continues a trend in ICRP reports towards physiologically realistic descriptions of the time-dependent behaviour of absorbed radionuclides and their radioactive progeny. This paper proposes systemic biokinetic models for caesium isotopes and their ingrowing chain members and examines the dosimetric implications of the proposed models. Comparisons of D68 = tissue dose per unit input to blood based on current ICRP models for workers (ICRP Publication 68, 1994) with DP = corresponding values based on the proposed biokinetic models (but using the dosimetry models of Publication 68) yields the following ranges of the ratios DP:D68 for the tissues addressed in Publication 68: 0.5–25 for 130Cs (T1/2 = 29.2 min), 0.6–9.5 for 134mCs (2.9 h), 0.7–1.7 for 131Cs (9.69 d), 0.7–1.1 for 134Cs (2.06 y), 0.5–1.9 for 137Cs (30.2 y) and 0.2–3.7 for 135Cs (2.3 × 106 y). The large differences in the derived dose coefficients for some tissues and caesium isotopes, particularly short-lived isotopes, result mainly from differences in predictions of the time-dependent distributions of caesium in the body. For example, the proposed model and the current ICRP model for occupational intake of caesium predict peak kidney contents of ∼22% and ∼0.4%, respectively, following intravenous injection of stable caesium. Based on the proposed models for caesium and its progeny, the only dosimetrically significant chain members of caesium isotopes with half-life ≥10 min are 137mBa, which represents 32–85% of the estimated tissue doses from injected 137Cs, and 134Cs, which represents 4–53% of the estimated tissue doses from injected 134mCs.

The argument has become very familiar - that radionuclides introduced into the environment from nuclear installations, fall-out from weapons testing, or whatever source, are responsible for substantial increases in cancer rates, and, because current risk estimates do not support this conclusion, they must be very wrong. It is argued that there must be some way in which low levels of artificial radionuclides, levels that result in tissue doses lower than from naturally-occurring radionuclides, pose a risk that is yet to be appreciated. One obvious problem with current risk estimates, it is suggested, is the simplistic averaging of doses from hot particles - see, for example, the home page of the Low Level Radiation Campaign website (www.llrc.org).